Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions.

Eisai reported strong Q3 2024 performance driven by its leading products, particularly LEQEMBI, which saw robust sales growth across key regions. Management expressed confidence in achieving its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eisai and Biogen update on lecanemab's EU regulatory review for early Alzheimer’s disease treatment following positive CHMP opinion. Eisai Co., Ltd. and Biogen Inc. have provided an update on ...

Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. FDA has accepted Eisai's Biologics License Application for lecanemab-irmb, marketed as LEQEMBI, which is designed for subcutaneous ...

Q ) What is the tyre size of Mahindra BE 6? A ) Mahindra BE 6 is available in 2 tyre sizes - 245/60 R18 and 245/55 R19. Q ) What are the specifications of the music system? A ) The specification ...